In this Q&A, Abdulrahman Alsuhibani, PharmD, discusses the results of his latest study examining the relationship between adverse events and the use of anti-obesity medications.
A new study, presented at the 2020 American Diabetes Association Scientific Sessions, adds to growing evidence of a so-called “obesity paradox” among patients hospitalized for diabetes.
Catherine Kotz, PhD, from the University of Minnesota and the Minneapolis VA Hospital, answered our questions about her research on spontaneous physical activity and the role orexin plays in preventing...
Obesity is a top-priority public health concern, with an estimated 650 million adults worldwide having obesity. Kirk I. Erickson, PhD, answered our questions to shed light on how physical activity...
New research published in the New England Journal of Medicine provides concerning estimates of the rates of obesity and severe obesity in the United States by 2030, with large disparities observed across...
Researchers investigated changes in the distribution of incident obesity-associated and non-obesity-associated cancers from 2000 to 2016 based on age, sex, and race/ethnicity.
While fecal microbiota transplantation from lean donors can have positive effects on metabolic syndrome, its effect in patients with obesity is not known. Researchers of a new study presented at Digestive...
To assess the impact of endoscopic sleeve gastroplasty on total body weight, authors of a study measured more than 5 years of weight-loss data of more than 200 individuals with obesity prior to the...
